U.S. Retail REITs Stock News

MSCI (MSCI) is back in focus after its May 2026 Equity Index Review set out additions and deletions across flagship benchmarks, a routine reshuffle that can still matter for passive fund flows and regional markets. See our latest analysis for MSCI. The May index review headlines arrive at a time when MSCI’s stock has eased back in the very short term, with the 1 day share price return down 1.75% and the 7 day share price return down 1.93%. However, the 90 day share price return of 9.32% and 3...

Recent performance snapshot Sensata Technologies Holding (ST) has caught investor attention after a strong run in its stock price over the past month and past 3 months, prompting closer scrutiny of its recent financial profile. The company reports annual revenue of US$3,728.0 million and net income of US$48.5 million, with revenue growth at 4.657% and net income growth at 26.439%. The stock last closed at US$48.19, giving Sensata a market cap of about US$6.47b. See our latest analysis for...

Etsy, NYSE:ETSY, is seeing intensifying competition that is linked to declining buyer activity. The company has reported an annual decline in active buyers and is projecting a sales contraction over the next year. Flat earnings growth alongside higher revenues has raised questions about Etsy's ability to turn demand into stronger profitability. Etsy, NYSE:ETSY, is coming under pressure as buyer activity softens, adding a new layer of risk for a stock that has already been volatile. Shares...

T. Rowe Price Group (NasdaqGS:TROW) has received approval for the merger of the Sionna Strategic Income Fund into the T. Rowe Price Global Allocation Fund. The transaction is set to combine the Sionna income focused mandate with T. Rowe Price's diversified global allocation strategy. The approved merger adds to T. Rowe Price's efforts to consolidate and streamline its product shelf for investors. T. Rowe Price Group operates as a global asset manager with a broad range of mutual funds and...

Maravai LifeSciences Holdings (NasdaqGS:MRVI) reported a 41% jump in Q1 2026 revenue. The company sharply narrowed its net loss and posted positive Adjusted EBITDA in the quarter. Results were supported by a large CleanCap vaccine order and meaningful debt reduction. For investors following NasdaqGS:MRVI, this Q1 2026 update marks a clear break from recent coverage that focused on ongoing losses and softer growth. The stock is trading at $4.37, with the share price up 10.9% over the past...

Bank of America (BAC) is back in focus after a robust Q1 2026 performance, an increase in full-year net interest income guidance, growing use of electronic bond trading through LTX, and record industry stock buybacks. See our latest analysis for Bank of America. Despite the strong Q1 2026 update and fresh fixed income issuances, momentum in the stock has cooled recently, with the share price down 7.01% over the past week and 10.92% year to date, even as the 1 year total shareholder return...

Flutter Entertainment (NYSE:FLUT) is back in focus after trimming its fiscal 2026 outlook and reporting first quarter results that combined strong sales with lower net income, along with leadership changes at core brand FanDuel. See our latest analysis for Flutter Entertainment. Those first quarter results, the trimmed 2026 outlook and leadership changes at FanDuel have come alongside a sharp reset in sentiment, with the share price down 56% year to date and the 1 year total shareholder...

Recent stock performance and what it might mean for Dollar Tree Dollar Tree (DLTR) has seen its stock fall about 15% over the past month and roughly 32% over the past 3 months, prompting investors to reassess how the business fundamentals line up with recent market sentiment. See our latest analysis for Dollar Tree. At a share price of US$86.80, Dollar Tree’s recent pressure, including a 7 day share price return down 10.06% and a 3 month share price return down 32.41%, contrasts with a...

Wondering if Brown-Forman's current share price reflects its true worth, or if the stock might be mispriced based on fundamentals and market expectations. The stock last closed at US$26.16, with returns that were roughly flat year to date at 0.1%, but with declines of 3.0% over the past week, 10.6% over the past month, and 22.4% over the past year, and 55.8% and 62.8% over the past 3 and 5 years respectively. These changes may affect how you think about both risk and potential future...

Harmonic (HLIT) is back in focus after raising its full year 2026 earnings guidance and outlining stronger broadband momentum, while moving ahead with the planned sale of its video business to concentrate on broadband. See our latest analysis for Harmonic. Investors have responded quickly to the stronger broadband story and higher 2026 guidance, with a 1 month share price return of 34.17% and a 1 year total shareholder return of 39.06%. The 3 year total shareholder return remains down 19.34%,...

CVS Health (NYSE:CVS) is divesting its Omnicare subsidiary to GenieRx, with the transaction approved by the U.S. Bankruptcy Court and awaiting regulatory approvals. The company is launching CVS Air Response, a drone-enabled healthcare logistics network with SkyfireAI and Thales Aerospace, focused on emergency and specialty pharmaceutical delivery. CVS Caremark plans to update its commercial formularies on July 1, 2026, prioritizing FDA-approved biosimilars for key treatments to support...

Expedia Group (NasdaqGS:EXPE) is expanding its B2B travel operations, supported by strong segment growth that now contributes a larger share of total revenue. The company is reported to be in talks to acquire CarTrawler, a move aimed at strengthening its car rental platform and wider partner offering. This potential deal and the faster B2B growth mark a shift in Expedia Group's business mix beyond its core consumer travel brands. For investors tracking NasdaqGS:EXPE, the focus has recently...

On April 30, 2026, Best Buy disclosed that two shareholder groups filed proposals asking for detailed reporting on risks tied to ESG and DEI-linked executive pay and on the financial rationale for investments highlighted in its 2025 Corporate Responsibility & Sustainability Report, while the company urged investors to vote against both at its upcoming June 12, 2026 meeting. This clash over ESG oversight and investment transparency highlights growing tension between activist shareholders...

If you are wondering whether Fluence Energy's current share price still offers value after a strong run, the numbers around recent performance and valuation checks are worth a closer look. The stock trades at US$22.10, with returns of 63.0% over the past week, 61.9% over the past month, a decline of 4.0% year to date, and 305.5% over the last year. This naturally raises questions about how much upside or risk is now priced in. Recent coverage has focused on Fluence Energy's role in energy...

Brunswick (NYSE:BC) is supplying marine platforms, propulsion and electronics for Textron Systems’ TSUNAMI uncrewed surface vessel fleet. The partnership focuses on modular, scalable systems designed for autonomy and defense applications for the U.S. Navy. This agreement extends Brunswick’s marine technology beyond recreational boating into dual use military programs. For investors watching NYSE:BC, this defense collaboration adds a new angle to a company better known for recreational...

TG Therapeutics recently reported past first-quarter 2026 results showing revenue of US$204.92 million and net income of US$19.78 million, while raising its full-year 2026 total global revenue target to about US$925 million, largely driven by higher expected BRIUMVI U.S. net product revenue of US$885 million to US$900 million. This combination of stronger earnings and higher guidance underlines how central BRIUMVI has become to TG Therapeutics’ business model and forward planning. We’ll now...

Insmed (INSM) has drawn fresh investor attention after reporting first quarter 2026 results that combined significant revenue contributions from BRINSUPRI and ARIKAYCE with a smaller net loss and reiterated full year guidance. See our latest analysis for Insmed. Despite the solid Q1 update and reiterated guidance, the stock has recently pulled back, with a 30 day share price return of down 21.93% and a year to date share price return of down 33.38%. At the same time, the 1 year total...

LendingClub (NYSE:LC) is rebranding as Happen Bank to reflect its technology focused banking model. The company is shifting its business toward serving institutional loan buyers rather than individual peer to peer investors. Happen Bank is expanding into home improvement lending, with plans to add home equity and mortgage products over time. For you as an investor, the Happen Bank rebrand marks a clear break from LendingClub's peer to peer roots and leans into its role as a digital bank...

Molina Healthcare and The MolinaCares Accord announced a new grant to support an empowerment and skills program for young adults with disabilities in Massachusetts. The initiative funds the Youth Empowerment Services, or YES, program, focused on building employment readiness and independence. The program targets young adults with disabilities and is positioned as a community-focused extension of Molina Healthcare's existing services. For investors watching NYSE:MOH, this new grant adds a...

Why Black Stone Minerals is on investors' radar Black Stone Minerals (BSM) has drawn fresh attention after recent trading left the stock roughly flat over the year to date, despite a market value of about US$2.87b and reported revenue of US$410.17 million. See our latest analysis for Black Stone Minerals. At a share price of US$13.55, Black Stone Minerals has seen its share price drift lower over the past three months while still producing a positive 1-year total shareholder return of 7.27%...

Event context and recent price move Sionna Therapeutics (SION) stock moved about 5.3% higher in the latest session, bringing the last close to US$43.12. That leaves the clinical stage cystic fibrosis specialist with a market value near US$1.85b. See our latest analysis for Sionna Therapeutics. The latest 5.3% 1 day share price return sits within a generally positive trend, with the 90 day share price return of 14.6% and a very large 1 year total shareholder return suggesting momentum has been...

In the past week, Artisan Mid Cap Fund disclosed a new position in Semtech, highlighting its high-performance connectivity chips for AI-driven data centers and pointing to a possible sale of the lower-quality Sierra Wireless unit to streamline the business. At the same time, some research platforms flagged Semtech’s shares as very expensive with insider selling of about US$3.2 million, underscoring a sharp divide between institutional optimism and valuation concerns. Next, we’ll explore...

Sempra (SRE) is back in focus after reporting first quarter 2026 results, with revenue of US$3,655 million, net income of US$1,037 million, and updated earnings guidance that reaffirmed its outlook for 2026 and 2027. See our latest analysis for Sempra. The share price has eased in the short term, with a 30 day share price return of 4.73% and a 7 day return of 2.12% both declining, even as the 1 year total shareholder return of 26.20% and 5 year total shareholder return of 57.92% point to...

BorgWarner (BWA) stock has been in focus after the company secured fresh eMotor and turbocharging awards with Asian and European automakers, reported higher year-over-year quarterly earnings, and reaffirmed full-year 2026 guidance. See our latest analysis for BorgWarner. BorgWarner’s recent eMotor and turbocharging wins, along with higher quarterly earnings and reaffirmed 2026 guidance, have coincided with a 24.85% 1 month share price return and a very strong 1 year total shareholder return...